European Perspectives


Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value

Federica Miglietta, Gaia Griguolo, Valentina Guarneri, Maria Vittoria Dieci

The Oncologist first published on August 23, 2019; doi:10.1634/theoncologist.2019-0197


Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis

Casper Reijnen, Joanna IntHout, Leon F.A.G. Massuger, Fleur Strobbe, Heidi V.N. Küsters‐Vandevelde, Ingfrid S. Haldorsen, Marc P.L.M. Snijders, Johanna M.A. Pijnenborg

The Oncologist first published on July 19, 2019; doi:10.1634/theoncologist.2019-0166


Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02)

Xabier García-Albéniz, Vicente Alonso, Pilar Escudero, Miguel Méndez, Javier Gallego, Jose Ramon Rodríguez, Antonia Salud, Julen Fernández-Plana, Hermini Manzano, Montserrat Zanui, Ester Falcó, Jaime Feliu, Mireia Gil, Carlos Fernández-Martos, Uriel Bohn, Carmen Alonso, Veró nica Calderero, Federico Rojo, Miriam Cuatrecasas, Joan Maurel

The Oncologist first published on June 24, 2019; doi:10.1634/theoncologist.2018-0728


Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update

Francesco Izzo, Vincenza Granata, Roberto Grassi, Roberta Fusco, Raffaele Palaia, Paolo Delrio, Gianpaolo Carrafiello, Daniel Azoulay, Antonella Petrillo, Steven A Curley

The Oncologist first published on June 19, 2019; doi:10.1634/theoncologist.2018-0337


Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey

Florence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, Daniel Lopez-Trabada-Ataz, Isabelle Baumgaertner, Olivier Dubreuil, Francesco Brunetti, Romain Coriat, Karin Maley, Simon Pernot, Christophe Tournigand, Meoin Hagege, Thomas Aparicio, Elena Paillaud, Sylvie Bastuji-Garin

The Oncologist first published on June 11, 2019; doi:10.1634/theoncologist.2019-0117


Long-Term Survivors in Metastatic Pancreatic Ductal Adenocarcinoma: A Retrospective and Matched Pair Analysis

Pauline Rochefort, Audrey Lardy-Cleaud, Matthieu Sarabi, Françoise Desseigne, Anne Cattey-Javouhey, Christelle de la Fouchardière

The Oncologist first published on June 4, 2019; doi:10.1634/theoncologist.2018-0786


Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study

Maria Vittoria Dieci, Valentina Guarneri, Fable Zustovich, Marta Mion, Paolo Morandi, Emilio Bria, Laura Merlini, Pierluigi Bullian, Cristina Oliani, Stefania Gori, Tommaso Giarratano, Enrico Orvieto, Gaia Griguolo, Silvia Michieletto, Tania Saibene, Paola Del Bianco, Gian Luca De Salvo, PierFranco Conte, on behalf of the Veneto Oncology Network

The Oncologist first published on May 31, 2019; doi:10.1634/theoncologist.2019-0103


Characteristics of BRAFV600E Mutant, Deficient Mismatch Repair/Proficient Mismatch Repair, Metastatic Colorectal Cancer: A Multicenter Series of 287 Patients

Christelle de la Fouchardiére, Romain Cohen, David Malka, Rosine Guimbaud, Héloïse Bourien, Astrid Lièvre, Wulfran Cacheux, Pascal Artru, Eric François, Marine Gilabert, Emmanuelle Samalin-Scalzi, Aziz Zaanan, Vincent Hautefeuille, Benoit Rousseau, Hélène Senellart, Romain Coriat, Ronan Flippot, Françoise Desseigne, Audrey Lardy-Cleaud, David Tougeron

The Oncologist first published on May 31, 2019; doi:10.1634/theoncologist.2018-0914


Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis

Ana Fernández Montes, Carlos López López, Guillem Argilés Martínez, David Páez López, Ana María López Muñoz, Beatriz García Paredes, David Gutiérrez Abad, Carmen Castañón López, Paula Jiménez Fonseca, Javier Gallego Plazas, María Carmen López Doldán, Eva Martínez de Castro, Manuel Sánchez Cánovas, María Tobeña Puyal, Beatriz Llorente Ayala, Ignacio Juez Martel, Mariana López Flores, Alberto Carmona-Bayonas

The Oncologist first published on May 30, 2019; doi:10.1634/theoncologist.2018-0824


Conformity to Clinical Practice Guidelines at Initial Management in Adult Soft Tissue and Visceral Tumors since the Implementation of the NetSarc Network in Eastern France

Justine Gantzer, Antonio Di Marco, Thibaut Fabacher, Noelle Weingertner, Jean-Baptiste Delhorme, David Brinkert, Guillaume Bierry, Jean-Pierre Ghnassia, Jérémie Jégu, Jean-Emmanuel Kurtz

The Oncologist first published on May 9, 2019; doi:10.1634/theoncologist.2018-0751


Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast Cancer

Giuseppe Curigliano, Evandro de Azambuja, Daniel Lenihan, Maria Grazia Calabrò, Daniela Cardinale, Carlo Maria Cipolla

The Oncologist first published on May 7, 2019; doi:10.1634/theoncologist.2018-0773


Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial

Astrid Lipplaa, Judith R. Kroep, Lizz van der Heijden, Paul C. Jutte, Pancras C.W. Hogendoorn, Sander Dijkstra, Hans Gelderblom

The Oncologist first published on April 30, 2019; doi:10.1634/theoncologist.2019-0280


A Pilot, Phase II, Randomized, Open-Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab-Paclitaxel to That of Solvent-Based Paclitaxel as the First-Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2-Negative Metastatic Breast Cancer

Eva Ciruelos, María Apellániz-Ruiz, Blanca Cantos, Noelia Martinez-Jáñez, Coralia Bueno-Muiño, Maria-Jose Echarri, Santos Enrech, Juan-Antonio Guerra, Luis Manso, Tomas Pascual, Cristina Dominguez, Juan-Francisco Gonzalo, Juan-Luis Sanz, Cristina Rodriguez-Antona, Juan-Manuel Sepúlveda

The Oncologist first published on April 25, 2019; doi:10.1634/theoncologist.2017-0664


Outcome of Patients with Soft-Tissue Sarcomas: An Age-Specific Conditional Survival Analysis

Kevin Bourcier, Derek Dinart, Axel Le Cesne, Charles Honoré, Pierre Meeus, Jean-Yves Blay, Audrey Michot, François Le Loarer, Antoine Italiano

The Oncologist first published on April 23, 2019; doi:10.1634/theoncologist.2018-0641


Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors

Alberto Pavan, Lorenzo Calvetti, Alessandro Dal Maso, Ilaria Attili, Paola Del Bianco, Giulia Pasello, Valentina Guarneri, Giuseppe Aprile, PierFranco Conte, Laura Bonanno

The Oncologist first published on April 23, 2019; doi:10.1634/theoncologist.2018-0563


Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population

Lucio Crinò, Paolo Bidoli, Angelo Delmonte, Francesco Grossi, Filippo De Marinis, Andrea Ardizzoni, Fabiana Vitiello, Giuseppe Lo Russo, Hector Soto Parra, Enrico Cortesi, Federico Cappuzzo, Luana Calabrò, Marcello Tiseo, Daniele Turci, Teresa Gamucci, Paola Antonelli, Alessandro Morabito, Antonio Chella, Diana Giannarelli, Domenico Galetta

The Oncologist first published on April 17, 2019; doi:10.1634/theoncologist.2018-0737


"How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer

Claribel Simmons, Donald C. McMillan, Sharon Tuck, Cat Graham, Alistair McKeown, Mike Bennett, Claire O'Neill, Andrew Wilcock, Caroline Usborne, Kenneth C. Fearon, Marie Fallon, Barry J. Laird, on behalf of the IPAC Study Group

The Oncologist first published on April 11, 2019; doi:10.1634/theoncologist.2018-0474


Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma

Rocio Garcia-Carbonero, Ivan Marquez-Rodas, Luis de la Cruz-Merino, Javier Martinez-Trufero, Miguel Angel Cabrera, Jose Maria Piulats, Jaume Capdevila, Enrique Grande, Salvador Martin-Algarra, Alfonso Berrocal

The Oncologist first published on April 8, 2019; doi:10.1634/theoncologist.2018-0718


HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer

Andrea Sartore-Bianchi, Alessio Amatu, Luca Porcu, Silvia Ghezzi, Sara Lonardi, Francesco Leone, Francesca Bergamo, Elisabetta Fenocchio, Erika Martinelli, Beatrice Borelli, Federica Tosi, Patrizia Racca, Emanuele Valtorta, Emanuela Bonoldi, Cosimo Martino, Caterina Vaghi, Giovanna Marrapese, Fortunato Ciardiello, Vittorina Zagonel, Alberto Bardelli, Livio Trusolino, Valter Torri, Silvia Marsoni, Salvatore Siena

The Oncologist first published on April 5, 2019; doi:10.1634/theoncologist.2018-0785


Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial

Chiara Nicolazzo, Gian Maria Busetto, Angela Gradilone, Isabella Sperduti, Francesco del Giudice, Flavia Loreni, Enrico Cortesi, Ettore de Berardinis, Paola Gazzaniga, Cristina Raimondi

The Oncologist first published on April 3, 2019; doi:10.1634/theoncologist.2018-0784


Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice

Alessandro Broccoli, Beatrice Casadei, Annalisa Chiappella, Carlo Visco, Monica Tani, Nicola Cascavilla, Annarita Conconi, Monica Balzarotti, Maria Christina Cox, Dario Marino, Maria Cecilia Goldaniga, Roberto Marasca, Cristina Tecchio, Caterina Patti, Gerardo Musuraca, Liliana Devizzi, Federico Monaco, Alessandra Romano, Angelo Fama, Michelle Zancanella, Rossella Paolini, Luigi Rigacci, Claudia Castellino, Francesco Gaudio, Lisa Argnani, Pier Luigi Zinzani

The Oncologist first published on April 2, 2019; doi:10.1634/theoncologist.2018-0603


Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy

Jan Trøst Jørgensen

The Oncologist first published on April 2, 2019; doi:10.1634/theoncologist.2019-0054


The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer

Aristotelis Bamias, Kimon Tzannis, Christina Bamia, Lauren C. Harshman, Simon Crabb, Elizabeth R. Plimack, Sumanta Pal, Ugo De Giorgi, Sylvain Ladoire, Christine Theodore, Neeraj Agarwal, Evan Y. Yu, Guenter Niegisch, Cora N. Sternberg, Sandy Srinivas, Ulka Vaishampayan, Andrea Necchi, Michalis Liontos, Jonathan E. Rosenberg, Thomas Powles, Joaquim Bellmunt, Matthew D. Galsky

The Oncologist first published on April 1, 2019; doi:10.1634/theoncologist.2018-0739


Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients’ Outcome in Neuroendocrine Tumors (NET)—The GREPONET Study

Angela Lamarca, Joakim Crona, Maxime Ronot, Marta Opalinska, Carlos Lopez Lopez, Daniela Pezzutti, Pavan Najran, Luciana Carvhalo, Regis Otaviano Franca Bezerra, Philip Borg, Naik Vietti Violi, Hector Vidal Trueba, Louis de Mestier, Niklaus Schaefer, Anders Sundin, Frederico Costa, Marianne Pavel, Clarisse Dromain, on behalf of The Knowledge Network

The Oncologist first published on March 25, 2019; doi:10.1634/theoncologist.2018-0672


The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia

Sahra Ali, Helen-Marie Dunmore, Dominik Karres, Justin L. Hay, Tomas Salmonsson, Christian Gisselbrecht, Sinan B. Sarac, Ole W. Bjerrum, Doris Hovgaard, Yolanda Barbachano, Nithyanandan Nagercoil, Francesco Pignatti

The Oncologist first published on March 21, 2019; doi:10.1634/theoncologist.2019-0025


Care for Smoking Cessation Must Be Proactive and Based on a Combination of Pharmacology and Psychology

Alain Braillon

The Oncologist first published on March 19, 2019; doi:10.1634/theoncologist.2018-0817


Inequalities in Financial Distress, Symptoms, and Quality of Life Among Patients with Advanced Cancer in France and the U.S.

Cécile Barbaret, Marvin O. Delgado-Guay, Stéphane Sanchez, Christelle Brosse, Murielle Ruer, Léa Monsarrat, Patrick Michaud, Anne Marie Schott, Eduardo Bruera, Mariléne Filbet

The Oncologist first published on March 15, 2019; doi:10.1634/theoncologist.2018-0353


Inhibition of Serotonin Synthesis May Have Antitumor Activity? Long‐Term Efficacy in a Patient with Gastrointestinal Neuroendocrine Tumor

Javier Molina-Cerrillo, Enrique Grande, Teresa Alonso-Gordoa

The Oncologist first published on March 15, 2019; doi:10.1634/theoncologist.2018-0776


Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas

My Le, Ytel Garcilazo, Maria-José Ibáñez‐Juliá, Nadia Younan, Louis Royer-Perron, Marion Benazra, Karima Mokhtari, Caroline Houillier, Khê Hoang‐Xuan, Agusti Alentorn

The Oncologist first published on March 13, 2019; doi:10.1634/theoncologist.2018-0629


Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

Sanchez, Sergio Vázquez, Narayanan Srihari, Haralabos Kalofonos, Petri Bono, Chaitali Babanrao Pisal, Yulia Hirschberg, Luca Dezzani, Qasim Ahmad, Eric Jonasch, on behalf of the PRINCIPAL Study Group

The Oncologist first published on March 13, 2019; doi:10.1634/theoncologist.2018-0787


Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series

Martin Benesch, Martin Mynarek, Hendrik Witt, Monika Warmuth‐Metz, Torsten Pietsch, Brigitte Bison, Stefan M. Pfister, Kristian W. Pajtler, Marcel Kool, Ulrich Schüller, Klaus Pietschmann, Björn‐Ole Juhnke, Stephan Tippelt, Gudrun Fleischhack, Irene Schmid, Christof M. Kramm, Peter Vorwerk, Andreas Beilken, Carl Friedrich Classen, Pablo Hernáiz Driever, Gabriele Kropshofer, Thomas Imschweiler, Andreas Lemmer, Rolf‐Dieter Kortmann, Stefan Rutkowski, Katja von Hoff

The Oncologist first published on March 8, 2019; doi:10.1634/theoncologist.2018-0489


From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study)

Giulia Pasello, Giovanni Vicario, Fable Zustovich, Francesco Oniga, Stefania Gori, Francesco Rosetti, Andrea Bonetti, Adolfo Favaretto, Silvia Toso, Roberta Redelotti, Antonio Santo, Daniele Bernardi, Petros Giovanis, Cristina Oliani, Lorenzo Calvetti, Carlo Gatti, Giovanni Palazzolo, Zora Baretta, Alberto Bortolami, Laura Bonanno, Marco Basso, Jessica Menis, Donatella Da Corte, Stefano Frega, Valentina Guarneri, PierFranco Conte, on behalf of Veneto Oncology Network

The Oncologist first published on March 7, 2019; doi:10.1634/theoncologist.2018-0712


The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer

Emne A. Abdallah, Alexcia C. Braun, Bianca C.T.C.P. Flores, Laís Senda, Ana Cláudia Urvanegia, Vinicius Calsavara, Victor Hugo Fonseca de Jesus, Maria Fernanda Arruda Almeida, Maria Dirlei Begnami, Felipe J.F. Coimbra, Wilson Luiz da Costa Jr, Diana Noronha Nunes, Emmanuel Dias-Neto, Ludmilla T. Domingos Chinen

The Oncologist first published on March 7, 2019; doi:10.1634/theoncologist.2018-0741


Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability

Amanda Hanora Lavan, Deirdre O'Mahony, Mary Buckley, Denis O'Mahony, Paul Gallagher

The Oncologist first published on March 4, 2019; doi:10.1634/theoncologist.2018-0476


Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

Alessio Cortellini, Sebastiano Buti, Daniele Santini, Fabiana Perrone, Raffaele Giusti, Marcello Tiseo, Melissa Bersanelli, Maria Michiara, Antonino Grassadonia, Davide Brocco, Nicola Tinari, Michele De Tursi, Federica Zoratto, Enzo Veltri, Riccardo Marconcini, Francesco Malorgio, Carlo Garufi, Marco Russano, Cecilia Anesi, Tea Zeppola, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Gian Carlo Antonini Cappellini, Federica De Galitiis, Maria Giuseppa Vitale, Roberto Sabbatini, Sergio Bracarda, Rossana Berardi, Silvia Rinaldi, Marianna Tudini, Rosa Rita Silva, Annagrazia Pireddu, Francesco Atzori, Rita Chiari, Biagio Ricciuti, Daniela Iacono, Maria Rita Migliorino, Antonio Rossi, Giampiero Porzio, Katia Cannita, Valeria Ciciarelli, Maria Concetta Fargnoli, Paolo Antonio Ascierto, Corrado Ficorella

The Oncologist first published on February 22, 2019; doi:10.1634/theoncologist.2018-0618


Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?

Enrico Franceschi, Alicia Tosoni, Dario De Biase, Giuseppe Lamberti, Daniela Danieli, Stefano Pizzolitto, Elena Zunarelli, Michela Visani, Enrico Di Oto, Antonella Mura, Santino Minichillo, Chiara Scafati, Sofia Asioli, Alexandro Paccapelo, Stefania Bartolini, Alba A. Brandes

The Oncologist first published on February 18, 2019; doi:10.1634/theoncologist.2018-0549


Can Peripherally Inserted Central Catheters Be Safely Placed in Patients with Cancer Receiving Chemotherapy? A Retrospective Study of Almost 400,000 Catheter-Days

Sara Campagna, Silvia Gonella, Paola Berchialla, Giacomo Morano, Carla Rigo, Pietro Antonio Zerla, Raffaella Fuzzi, Gianvito Corona, Silvana Storto, Valerio Dimonte, Baudolino Mussa

The Oncologist first published on February 12, 2019; doi:10.1634/theoncologist.2018-0281


Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement

Ramon Colomer, Cristina Saura, Pedro Sánchez-Rovira, Tomás Pascual, Isabel T. Rubio, Octavio Burgués, Lourdes Marcos, César A. Rodríguez, Miguel Martín, Ana Lluch

The Oncologist first published on February 1, 2019; doi:10.1634/theoncologist.2018-0228


Changes in the Use of Comprehensive Geriatric Assessment in Clinical Trials for Older Patients with Cancer over Time

Olivia Le Saux, Claire Falandry, Hui K. Gan, Benoit You, Gilles Freyer, Julien Péron

The Oncologist first published on February 1, 2019; doi:10.1634/theoncologist.2018-0493


Suspected Hereditary Cancer Syndromes in Young Patients: Heterogeneous Clinical and Genetic Presentation of Colorectal Cancers

Claudia Maletzki, Maja Hühns, Ingrid Bauer, Friedrich Prall, Christian Junghanss, Larissa Henze

The Oncologist first published on on January 25, 2019; doi:10.1634/theoncologist.2018-0614


Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2

Aleix Prat, Jan Christoph Brase, Yuan Cheng, Paolo Nuciforo, Laia Paré, Tomás Pascual, Débora Martínez, Patricia Galván, Maria Vidal, Barbara Adamo, Gabriel N. Hortobagyi, José Baselga, Eva Ciruelos

The Oncologist first published on January 24, 2019; doi:10.1634/theoncologist.2018-0407


Diagnosis and Treatment Monitoring of a Patient with Gastrointestinal Stromal Tumor by Next-Generation Sequencing and Droplet Digital Polymerase Chain Reaction Assay of a PDGFRA Mutation in Plasma-Derived Cell-Free Tumor DNA

Pieter A. Boonstra, Arja ter Elst, Marco Tibbesma, Jourik A. Gietema, Ed Schuuring, Anna K.L. Reyners

The Oncologist first published on January 22, 2019; doi:10.1634/theoncologist.2018-0460


Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group

Gabriel G. Malouf, Guillaume Beinse, Julien Adam, Olivier Mir, Ali N. Chamseddine, Philippe Terrier, Charles Honore, Jean-Philippe Spano, Antoine Italiano, Jean-Emmanuel Kurtz, Jean-Michel Coindre, Jean-Yves Blay, Axel Le Cesne

The Oncologist first published on January 9, 2019; doi:10.1634/theoncologist.2018-0074


T-Cell Lymphopenia in Patients with Advanced Thyroid Carcinoma Is Associated with Poor Prognosis

Katrin Rabold, Paul R. Gielen, Esther D. Kers-Rebel, Mihai G. Netea, Jan W.A. Smit, Gosse J. Adema, Romana T. Netea-Maier

The Oncologist first published on January 3, 2019; doi:10.1634/theoncologist.2018-0422


Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Claudio Vernieri, Fabio Galli, Laura Ferrari, Paolo Marchetti, Sara Lonardi, Evaristo Maiello, Rosario V. Iaffaioli, Maria G. Zampino, Alberto Zaniboni, Sabino De Placido, Maria Banzi, Azzurra Damiani, Daris Ferrari, Gerardo Rosati, Roberto F. Labianca, Paolo Bidoli, Giovanni L. Frassineti, Mario Nicolini, Lorenzo Pavesi, Maria C. Tronconi, Angela Buonadonna, Sabrina Ferrario, Giovanni Lo Re, Vincenzo Adamo, Emiliano Tamburini, Mario Clerico, Paolo Giordani, Francesco Leonardi, Sandro Barni, Andrea Ciarlo, Luigi Cavanna, Stefania Gori, Saverio Cinieri, Marina Faedi, Massimo Aglietta, Maria Antista, Katia F. Dotti, Francesca Galli, Maria Di Bartolomeo, on behalf of TOSCA (Three or Six Colon Adjuvant) Investigators

The Oncologist first published on January 3, 2019; doi:10.1634/theoncologist.2018-0442


Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer

Marloes G.M. Derks, Cornelis J.H. van de Velde, Daniele Giardiello, Caroline Seynaeve, Hein Putter, Johan W.R. Nortier, Luc Y. Dirix, Esther Bastiaannet, Johanneke E.A. Portielje, Gerrit-Jan Liefers

The Oncologist first published on January 3, 2019; doi:10.1634/theoncologist.2018-0010


Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy

Santiago Cabezas-Camarero, Virginia de la Orden García, Vanesa García-Barberán, Beatriz Mediero-Valeros, Ahmad Issa Subhi-Issa, Patricia Llovet García, Inmaculada Bando-Polaino, Salomé Merino Menéndez, Pedro Pérez-Segura, Eduardo Díaz-Rubio

The Oncologist first published on January 2, 2019; doi:10.1634/theoncologist.2018-0387


European Articles Archive

Links to other domains will open in a new tab or window.